newswirelogo

  • SIX-MONTH ANALYSIS OF PATIENT AND PROCEDURE VOLUME AT 275 HOSPITALS SHOWS AN INDUSTRY IN SLOW RECOVERY
    SIX-MONTH ANALYSIS OF PATIENT AND PROCEDURE VOLUME AT 275 HOSPITALS SHOWS AN INDUSTRY IN SLOW RECOVERY
  • BUENA, N.J., Sept. 23, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced the closing of the issuance of approximately $27.5 million aggregate principal amount of Zero Coupon Convertible Senior Notes due 2023 (the “New 2023 Notes”) in exchange for approximately $57.9 million in aggregate principal amount, plus accrued but unpaid interest, of the Company’s outstanding 4.75% Convertible Senior Notes due May 2023 (the “Series A Convertible Notes”), which gives effect to a 52.5% discount on the principal amount of Series A Convertible Notes exchanged. The Company also issued approximately $0.4 million aggregate principal amount of New 2023 Notes in exchange for approximately $0.5 million in aggregate principal amount, plus accrued but unpaid interest, of the Company’s outstanding 7.0% Cash / 8.0% PIK Series B Senior Unsecured Convertible Notes due 2023 (the “Series B Convertible Notes”), which gives effect to a 31% discount on the principal amount of Series B Convertible Notes exchanged.

  • Mil-Aero applications, RHBD ICs, Global Foundries, FinFET, MemoryIP
    Mil-Aero applications, RHBD ICs, Global Foundries, FinFET, MemoryIP
  • WIXOM, Mich., Sept. 23, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced that it has entered into securities purchase agreements with several healthcare-focused and other institutional investors to purchase 23,178,809 of its shares of common stock (or common stock equivalents in lieu thereof) and short-term warrants to purchase up to an aggregate of 23,178,809 shares of common stock, in a registered direct offering priced at-the-market under Nasdaq rules.  The combined purchase price for one share of common stock (or common stock equivalent) and a warrant to purchase one share of common stock is $1.51. The warrants have an exercise price of $1.80 per share, will be immediately exercisable, and will expire 24 months from the issue date.

  • 5G applications, mmWave ICs, Global Foundries, Low Leakage, MemoryIP
    5G applications, mmWave ICs, Global Foundries, Low Leakage, MemoryIP

Contact Us

Construction Today Magazine

Cringleford Business Centre
Intwood Road
Cringleford, Norwich, UK
NR4 6AU

Click here for a full list of contacts.

Back To Top